GlassScriptPhysician profile
Jeffrey D Friedman
NPI 1942235114
$2,790.77
in general payments reported to CMS, 2019-2025
23 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $133 · 2021: $528 · 2022: $501 · 2023: $579 · 2024: $512 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187 · Travel and Lodging: $12.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.65 |
| Travel and Lodging | $12.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $383.14 | 2019-2022 | |
| Abbvie INC. | $348.14 | 2021-2025 | |
| Sientra, INC. | $327.80 | 2021-2022 | |
| Davol INC. | $201.85 | 2020-2022 | |
| Mentor Worldwide LLC | $176.60 | 2019-2021 | |
| Medtronic, INC. | $171.98 | 2022-2024 | V-Loc 180 |
| Ethicon US, LLC | $153.47 | 2024-2025 | Stratafix, Surgicel Nu-Knit, Vistaseal |
| Musculoskeletal Transplant Foundation INC. | $137.56 | 2023 | |
| Motiva USA, LLC | $134.15 | 2024 | |
| Zimmer Biomet Holdings, INC. | $115.39 | 2019 | |
| Alafair Biosciences, INC. | $113.28 | 2022-2023 | Versawrap |
| Depuy Synthes Sales INC. | $112.51 | 2023 | Matrixmandible |
| Vioptix INC | $107.51 | 2020 | |
| Integra Lifesciences Corporation | $66.30 | 2023 | Durasorb Monofilament Mesh |
| Tela Bio, INC. | $58.01 | 2019-2024 | Ovitex 2s |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $49.17 | 2023 | Stravix Pl |
| Baxter Healthcare | $36.26 | 2024 | Perclot |
| Wound Management Technologies, INC | $25.50 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.40 | 2025 | |
| Mesh Suture INC | $20.47 | 2023 | |
| Galderma Laboratories, L.P. | $18.64 | 2021 | |
| Kerecis Limited | $8.64 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Friedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.